ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Terumo Corp (PK)

Terumo Corp (PK) (TRUMY)

20,39
0,00
(0,00%)
Geschlossen 02 Dezember 10:00PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
20,39
Gebot
20,39
Fragen
20,39
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
20,39
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
1.468.410.622
Dividendenrendite
1.45%
Kurs-Gewinn-Verhältnis
0,30
Gewinn pro Aktie (EPS)
72,44
Erlöse
930,27B
Nettogewinn
106,37B

Über Terumo Corp (PK)

Sektor
Surgical,med Instr,apparatus
Branche
Health Care Diversified
Website
Hauptsitz
Shibuya, Tokyo, Jpn
Gegründet
1984
Terumo Corp (PK) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker TRUMY. The last closing price for Terumo (PK) was US$20,39. Over the last year, Terumo (PK) shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Terumo (PK) currently has 1.468.410.622 shares in issue. The market capitalisation of Terumo (PK) is US$29,94 billion. Terumo (PK) has a price to earnings ratio (PE ratio) of 0.30.

TRUMY Neueste Nachrichten

China Diabetes Management Devices Market Growth to be Driven by Rise in Sedentary Lifestyle and Life Expectancy and Patient C...

China Diabetes Management Devices Market Growth to be Driven by Rise in Sedentary Lifestyle and Life Expectancy and Patient Compliant Technologies Especially for Insulin Pump and CGM PR...

Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013

Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013 PR Newswire LONDON and NEW YORK, December 1, 2014 LONDON and NEW YORK...

CareFusion, Terumo Sign Distribution Agreement For IV Catheters

CareFusion, Terumo Sign Distribution Agreement For IV Catheters Eight-Year Exclusive Agreement for CareFusion to Market SurFlash® Catheters in U.S. Acute Care Segment PR Newswire SAN DIEGO, Jan...

MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm ...

MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion PR Newswire TUSTIN, Calif., July 22, 2013 TUSTIN...

Terumo Medical Corporation Obtains Withdrawal By Vascular Solutions Of The R-Band™ Radial Hemostasis Device

Terumo Medical Corporation Obtains Withdrawal By Vascular Solutions Of The R-Band™ Radial Hemostasis Device Court Enters Order Under Which Vascular Solutions Will Cease Manufacture, Sales and...

MicroVention's New Manufacturing Plant Facility In Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony

MicroVention's New Manufacturing Plant Facility In Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony PR Newswire TUSTIN, Calif., March 6, 2013 TUSTIN, Calif., March 6, 2013...

Terumo Interventional Systems Targets Growth With New Focus on U.S. Urology Specialty

Terumo Interventional Systems Targets Growth With New Focus on U.S. Urology Specialty April 1, 2013, Marks Start of Company's Direct Distribution and Product Support of GLIDEWIRE® Hydrophilic...

Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company

Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company PR Newswire SOMERSET, N.J., Feb. 19, 2013 SOMERSET, N.J., Feb. 19, 2013...

Terumo Completes U.S. Patient Enrollment in the OSPREY Trial to Evaluate the MISAGO Self-expanding Stent

Terumo Completes U.S. Patient Enrollment in the OSPREY Trial to Evaluate the MISAGO Self-expanding Stent Unique Study Is Part of FDA's "Harmonization by Doing" Program to Streamline Product...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AABVFAberdeen International Inc (PK)
US$ 0,03638
(0,00%)
0
AABKFAareal Bank AG (PK)
US$ 0,00
(0,00%)
0
AABBAsia Broadband Inc (PK)
US$ 0,02275
(0,00%)
0
AAALYAareal Bank AG (PK)
US$ 34,65
(0,00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0,55
(0,00%)
0
AABVFAberdeen International Inc (PK)
US$ 0,03638
(0,00%)
0
AABKFAareal Bank AG (PK)
US$ 0,00
(0,00%)
0
AABBAsia Broadband Inc (PK)
US$ 0,02275
(0,00%)
0
AAALYAareal Bank AG (PK)
US$ 34,65
(0,00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0,55
(0,00%)
0
AABVFAberdeen International Inc (PK)
US$ 0,03638
(0,00%)
0
AABKFAareal Bank AG (PK)
US$ 0,00
(0,00%)
0
AABBAsia Broadband Inc (PK)
US$ 0,02275
(0,00%)
0
AAALYAareal Bank AG (PK)
US$ 34,65
(0,00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0,55
(0,00%)
0
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock